• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 541930 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416986647 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416986647 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Myriad Genetics Crosses Below its 10-day MA (MYGN)

Published on Mon, 07/29/2013 - 11:43
By Mallory Stone

Myriad Genetics (NASDAQ:MYGN) crossed under its 10-day moving average of $31.13 on a volume of 578K shares. This may provide swing traders with an opportunity for a short position, as such a crossover often suggests lower prices in the near term.

In the past 52 weeks, Myriad Genetics share prices have been bracketed by a low of $17.51 and a high of $38.27 and are now at $30.39, 74% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has declined 0.5%.

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Myriad Genetics has overhead space with shares priced $30.39, or 18.5% below the average consensus analyst price target of $37.27. The stock should discover initial support at its 50-day moving average (MA) of $30.35 and subsequent support at its 200-day MA of $27.92.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Shares of Ventas Rise Above Previous 52-...

Ventas (NYSE:VTR) traded today at a new 52-week high of $70.11. So far today approxima ...

Shares of Validus Holdings Rise to a New...

Shares of Validus Holdings (NYSE:VR) traded at a new 52-week high today of $41.42. So ...

Watch for Continued Gains in Shares of V...

Shares of VF Corp (NYSE:VFC) traded today at $74.38, breaking its 52-week high. This n ...

Shares of Valspar Have Risen Above Previ...

Valspar (NYSE:VAL) traded at a new 52-week high today of $87.59. Approximately 849,000 ...

Visa: The Winning Streak Continues (V)...

Visa (NYSE:V) traded today at a new 52-week high of $258.00. So far today approximatel ...

Union Pacific Looks to Continue to Trade...

Union Pacific (NYSE:UNP) traded today at a new 52-week high of $123.61. This new high ...

Shares of Textron Have Risen Above Previ...

Textron (NYSE:TXT) traded at a new 52-week high today of $44.47. This new high was rea ...

Shares of Take-Two Interactive Software ...

Take-Two Interactive Software (NASDAQ:TTWO) traded today at a new 52-week high of $28.0 ...